IBRX – immunitybio, inc. (US:NASDAQ)
Stock Stats
News
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunityBio, Inc. - IBRX
ImmunityBio Expands Access to ANKTIVA® in EU with New Distribution Partnership and Opens Irish Subsidiary to Support European Launch
ImmunityBio (IBRX) Is Up 29.0% After EU Clears First ANKTIVA+BCG Immunotherapy For NMIBC CIS [Yahoo! Finance]
ImmunityBio's EU Anktiva Nod Sparks Questions On Valuation And Momentum [Yahoo! Finance]
Form 8-K ImmunityBio, Inc. For: Feb 18
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: SOON-SHIONG PATRICK
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: LAUER REGAN J
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: Sachs David C.
Form 4 ImmunityBio, Inc. For: Feb 10 Filed by: Adcock Richard
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.